15 results
Keyword Ipilimumab Remove keyword
Categories
Human Remove Human filter
-
List item
Press release: New treatment option recommended for patients with advanced melanoma
CHMP, Last updated: 22/05/2015other comparing Keytruda with ipilimumab, another melanoma treatment … had not previously received ipilimumab and in patients who had previously … who had previously received ipilimumab. The Committee also looked … -
List item
Press release: European Medicines Agency recommends approval of Tafinlar for the treatment of metastatic melanoma
CHMP, Last updated: 28/06/2013them, the monoclonal antibody ipilimumab, targets a molecule found … them, the monoclonal antibody ipilimumab, targets a molecule found … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2020
CHMP, Last updated: 28/02/2020ipilimumab) in the treatment of metastatic … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2018
CHMP, Last updated: 16/11/2018ipilimumab) in combination to treat … -
List item
Press release: European Medicines Agency recommends approval of Mekinist for the treatment of melanoma
CHMP, Last updated: 25/04/2014including a monoclonal antibody (ipilimumab) that targets a molecule … a monoclonal antibody (ipilimumab) that targets a molecule … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018
CHMP, Last updated: 21/09/2018ipilimumab) have requested re-examination … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018ipilimumab) in combination to treat … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 April 2018
CHMP, Last updated: 27/04/2018Name of medicine Yervoy INN ipilimumab Marketing-authorisation holder … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2017
CHMP, Last updated: 15/12/2017Name of medicine Yervoy INN ipilimumab Marketing-authorisation holder … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2013
CHMP, Last updated: 20/09/2013Yervoy INN ipilimumab Marketing-authorisation holder … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2011
CHMP, Last updated: 20/05/2011ipilimumab), from Bristol-Myers Squibb … 210 days. • Yervoy (ipilimumab), from Bristol-Myers Squibb … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2020
CHMP, Last updated: 18/09/2020Yervoy INN ipilimumab Marketing-authorisation applicant … -
List item
News: European Medicines Agency increases transparency of ongoing applications for human medicines
PRAC, Last updated: 07/11/2012 -
List item
Press release: Meeting highlights from the Paediatric Committee: 17 - 19 September 2008
PDCO, Last updated: 28/09/2008area of haematology; Ipilimumab, from Bristol-Myers Squibb … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021
PRAC, Last updated: 12/02/2021